Dr Urvi Parikh is an Associate Professor of Medicine at University of Pittsburgh Department of Medicine, Division of Infectious Diseases. Her research focuses on examining the risk of HIV-1 drug resistance with the use of antiretrovirals for HIV prevention. She co-leads the ACTION and SeroPrEP studies, is the Associate Director of the AIDS Clinical Trial Group (ACTG) Virology Specialty Lab, and is HIV Drug Resistance Technical Lead of the USAID/PEPFAR Maximizing Options to Advance Informed Choice for HIV Prevention (MOSAIC) project. She was also the Associate Director of the Microbicide Trials Network (MTN) Virology Core, and has served as protocol virologist for studies evaluating the safety and efficacy of candidate antiretroviral products for HIV prevention. Her laboratory conducts sensitive assays to diagnose, genotype and phenotype HIV-1 and conducts preclinical research towards the development of new agents for HIV prevention.
Urvi M. Parikh, PhD
Virology Associate Specialty Lab Director